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Introduction {#sec1}
============

In most mammals, the first cellular specification event is believed to be acquisition of placental or non-placental identity ([@bib34]). Distinct polarized outer and apolar inner cell populations form during the morula phase of development. In the subsequent blastocyst stage, the outer cells give rise to the trophoblast lineage and later form most cells in the placenta. The inner cells give rise to the inner cell mass, which specifies both the hypoblast and pluripotent epiblast. The epiblast generates all embryonic tissues (ectoderm, mesoderm, and endoderm) of the organism. The observations above have been demonstrated by lineage tracing, blastomere transplantation, and chimera experiments in mice ([@bib5]). On the basis of observation, immunofluorescent staining, and RNA sequencing (RNA-seq), it is likely that human development follows a similar pattern ([@bib27], [@bib41]).

After implantation of the blastocyst into the uterine wall, the trophoblast lineage develops rapidly. Structures called villi sprout and expand. Cytotrophoblasts (CTBs), a population of epithelial cells within the villi, fuse to form syncytiotrophoblasts (STBs), large multinucleated cells that line the surface of the villi, secrete pregnancy hormones, and mediate gas and nutrient exchange with maternal blood. At the tips of villi that contact maternal tissue, CTBs undergo epithelial to mesenchymal transition and differentiate into extravillous trophoblasts (EVTs). EVTs invade maternal tissue, expand and anchor the villi, and remodel maternal arterioles ([@bib20]).

Meanwhile, the epiblast undergoes a series of changes, including epithelialization, increased DNA methylation, and expression of a new set of genes and cell surface receptors. These changes prime the epiblast to differentiate rapidly in response to external cues during subsequent gastrulation. As such, the epiblast is said to transition from the "naive" pluripotent state to the "primed" pluripotent state ([@bib28]). Upon gastrulation, the epiblast differentiates, and pluripotency is lost.

Stem cells have been used to study these developmental stages in mice and humans. In mice, embryonic stem cells (ESCs) can be cultured from the blastocyst inner cell mass, exhibit naive pluripotency, and can be differentiated into all embryonic lineages ([@bib28]). Likewise, murine trophoblast stem cells (mTSCs) can be isolated from blastocysts or early post-implantation embryos and can form all placental lineages ([@bib44]). Unlike ESCs, which reflect a brief developmental window artificially perpetuated *in vitro*, mTSCs are actually present in mouse embryos. Their niche is a structure called the extra-embryonic ectoderm, which forms shortly after implantation and lacks a human counterpart ([@bib20], [@bib44], [@bib50]). Reflecting their cells of origin, mESCs and mTSCs are fixed in their specifications. In chimera assays, mESCs and mTSCs contribute only to embryonic and placental lineage, respectively. mESCs cannot be converted to mTSCs *in vitro* except by genetic manipulation ([@bib29]), and even then the resulting cells are incompletely reprogrammed ([@bib4]).

Finding human counterparts for these stem cells has proven to be more complicated, and their behavior has not always matched that of the murine counterpart. As with mice, human ESCs (hESCs) can be isolated from pre-implantation blastocysts ([@bib47]). However, in conventional medium (with serum and fibroblast growth factor 2 \[FGF2\]), hESCs have an epithelial morphology, high levels of DNA methylation, and a transcriptome resembling primed post-implantation epiblast ([@bib25], [@bib28]). Several formulations for culturing naive hESCs have been developed. Two formulations, 5iLAF ([@bib46]) and t2iL + Gö ([@bib43]), show low DNA methylation and strong reactivation of pre-implantation genes, while other formulations show intermediate positions on the naive-primed spectrum ([@bib32]).

Efforts to obtain human trophoblast stem cells (hTSCs) from blastocysts using culture conditions analogous to murine TSCs have not been successful ([@bib16]). Primed hESCs treated with BMP4 and inhibitors of Activin and FGF signaling upregulate placental genes ([@bib2]). However, the resulting cells differentiate and quickly stop dividing. Furthermore, there is argument as to whether they more closely resemble placenta or mesoderm ([@bib37]), with some evidence suggesting partial but incomplete reprogramming to a placenta-like state ([@bib17]). Recently, hTSCs were successfully derived from first-trimester placental villi and pre-implantation blastocysts ([@bib31]). Self-renewing placental organ cultures have also been derived from first-trimester placenta ([@bib14], [@bib48]). hTSCs are clearly placental, have a very long or indefinite replicative life, and can differentiate to EVTs and STBs. hTSCs are epithelial cells and share key surface markers with villous CTBs. It remains unclear whether hTSCs are simply CTBs successfully adapted to *in vitro* culture or if they represent a CTB subpopulation or precursor.

Intriguingly, naive hESCs may reflect an earlier or less-fixed developmental state than mESCs. Their pattern of gene and transposon expression is especially primitive, corresponding to early epiblast or even late morula ([@bib45]). Naive hESCs show some features typically associated with placental cells, including high TFAP2C levels ([@bib33]) and nuclear localization of YAP protein ([@bib35]). A recent paper reported the existence of a subpopulation of cells in t2iL + Gö naive culture that had an expression pattern dissimilar from both naive and primed hESCs ([@bib22]). The identity of these cells was not determined, but they show upregulated expression of placental markers, such as *VGLL1*, *GATA2*, *GATA3*, and *XAGE3*, and are negative for the pluripotency markers *OCT4* and *NANOG*. Thus, even hESCs cultured in naive medium may undergo spontaneous differentiation to placental lineage.

We sought to determine whether naive hESCs can differentiate to the trophoblast lineage and form hTSCs. In addition to helping us understand the nature of naive human pluripotency, such a capability would allow generation of hTSC lines from existing hESC lines and could potentially be used to model human placental specification.

Results {#sec2}
=======

Similarity of hTSCs to Stem Cells in First-Trimester Placenta {#sec2.1}
-------------------------------------------------------------

To compare hTSCs and cells differentiated *in vitro* with primary placental cells, we conducted principal-component analysis (PCA) of published RNA-seq data from hTSCs and primary placental cell types ([@bib31]). hTSCs clustered closer to CTBs than to differentiated EVTs and STBs, with *in-vitro*-differentiated cells positioned relatively close to their isolated *in vivo* counterparts ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Yet, there was still considerable distance between hTSCs and CTBs. While this may partially reflect adaptation to *in vitro* culture, we considered that hTSCs may represent a distinct subpopulation of CTBs.

A recent report described a subpopulation of proliferative cells at the base of the CTB cell column in first-trimester placental villi ([@bib18]). These cells appear to give rise to EVTs and STBs and may be the core stem cell population in first-trimester placenta. These cells upregulate a number of genes relative to both CTBs and EVTs, and are distinguished by the surface markers ITGA2 and EpCAM ([@bib18]). Interestingly, hTSCs express far higher levels of *ITGA2* and *EPCAM* than bulk CTBs ([Figure 1](#fig1){ref-type="fig"}A). Furthermore, genes identified as upregulated in these primary ITGA2^+^ EpCAM^+^ cells are expressed at globally higher levels in hTSCs than CTBs or differentiated placental cells ([Figure 1](#fig1){ref-type="fig"}B). We confirmed by flow cytometry that hTSCs are strongly positive for ITGA2 and EpCAM and downregulate expression of these genes upon differentiation ([Figures 1](#fig1){ref-type="fig"}C, 1D, and [S1](#mmc1){ref-type="supplementary-material"}B). Together, these data suggestthat hTSCs may correspond to a real reported stem cell population in placenta and may explain some of the modest divergence observed between CTBs and hTSCs. Also, although neither marker is specific to placenta, ITGA2 and EpCAM may be used to sort hTSCs from heterogeneous populations.Figure 1Similarity of hTSCs to reported ITGA2^+^ EpCAM^+^ Progenitor Population(A) Expression of *ITGA2* and *EPCAM* in hTSCs and primary placenta cells. Data are taken from [@bib31], with n = 3--4 independent experiments per cell type.(B) Seventy-four genes were identified as upregulated in ITGA2^+^ cells by [@bib18] and also present in Okae et al.\'s RNA-seq dataset. The expression of these genes is plotted using RNA-seq data from Okae et al., with each gene represented as a single point in the boxplot.(C) Flow cytometry plot of ITGA2 and EpCAM in CT1 hTSCs and EVT. Representative of n = 5 independent experiments.(D) Downregulation of ITGA2 upon directed differentiation of CT1 (qRT-PCR, mean + SE of n = 2 independent experiments).

Transdifferentiation of Naive hESCs to Putative hTSCs {#sec2.2}
-----------------------------------------------------

To determine whether naive hESCs could be converted to placental lineage, we used an established reporter line (WIBR3 OCT4-ΔPE-GFP) that expresses GFP only upon acquisition of naive pluripotency ([@bib46]). We treated the cells with a rapid naive induction protocol that entails culture with PXGL media ([@bib13]), an improved version of the well-established t2iL + Gö naive media ([@bib43]). We observed GFP^+^ colonies with dome-shaped naive morphology ([Figures 2](#fig2){ref-type="fig"}A and 2B) and strong upregulation of naive markers ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Ten days after the start of reversion, we plated the hESCs directly into hTSC medium. Although a mixed population of cells formed, within 4 days of transition we observed colonies of epithelial cells that resembled hTSCs ([Figure 2](#fig2){ref-type="fig"}C) and stained strongly positive for the pan-placental markers KRT7 and TFAP2C and the CTB marker TEAD4 ([Figure 2](#fig2){ref-type="fig"}D). After 11 days of culture in hTSC medium, we sorted a pure population of putative hTSCs using the surface marker profile ITGA2^hi^ EpCAM^hi^ ITGA1^lo^ ([Figure 2](#fig2){ref-type="fig"}E). ITGA2 and EpCAM were chosen on the basis of the observations above, and ITGA1 was selected against because it is expressed on differentiated placental cells ([@bib24]) but is low in hTSCs ([Figures 2](#fig2){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}B). We also stained for HLA-G to gate against differentiated HLA-G^hi^ cells, although we eventually ceased use of this marker because it was less sensitive than ITGA1. The resulting transdifferentiated hTSC (tdhTSC) line (termed WIBR3-tdhTSC line 1) was morphologically indistinguishable from hTSCs of placental origin ([Figure 2](#fig2){ref-type="fig"}F) and had similar surface marker expression ([Figure S2](#mmc1){ref-type="supplementary-material"}C). To rule out the possibility of contamination with placental hTSCs, we conducted short tandem repeat (STR) analysis and confirmed that WIBR3-tdhTSC L1 has the same genetic markers as the starting WIBR3 hESCs ([Table S1](#mmc2){ref-type="supplementary-material"}). A list of all transdifferentiations conducted and cell lines generated in this paper are included in [Table S2](#mmc3){ref-type="supplementary-material"}.Figure 2Transdifferentiation of hESCs to Putative hTSCs and Purification via FACS Sorting(A) Upper panel: light microscopy image of a colony of primed WIBR3 OCT4-ΔPE-GFP hESCs, with the colony circled with a dashed line. Lower panel: lack of GFP signal.(B) Light and fluorescent image of WIBR3 OCT4-ΔPE-GFP hESCs after 10 days of naive reversion. Many GFP^+^ colonies are present, with one representative colony circled.(C) Naive hESCs after 4 days of culture in hTSC medium. Note the presence of a colony of epithelial cells and the loss of GFP signal.(D) Immunofluorescent image of WIBR hESCs after 10 days in hTSC medium. Note a distinct population of TFAP2C^+^ TEAD4^+^ KRT7^+^ cells.(E) FACS of WIBR3 hESCs grown in hTSC medium for 11 days and comparison CT1 hTSCs. Note distinct population of ITGA2^hi^ EpCAM^hi^ cells which was sorted to produce WIBR3 tdhTSC line 1.(F) Light microscopy of CT1 and WIBR3 tdhTSC line 1.(G) Flow cytometry of WIBR3 OCT4-ΔPE-GFP hESCs in naive (green) and primed (black) conditions are overlaid. GFP^hi^ and GFP^lo^ cells from naive culture, populations indicated with boxes, were sorted into hTSC medium.(H) Flow cytometry of GFP^hi^ and GFP^lo^ cells after 16 days in hTSC medium. Note much higher EpCAM^hi^ ITGA2^hi^ population in the GFP^hi^ population.(I) Immunofluorescent staining for hTSC/CTB (TEAD4) and pan-placental (TFAP2C, KRT7) markers in lines indicated. Representative of n = 2 independent experiments.

As discussed in the introduction, there is evidence that a very small proportion of cells in t2iL + Gö steady-state culture may already express placental markers, and it is possible that some cells in naive culture conditions have not fully attained naive state. To establish that genuine naive hESCs, rather than a side population, are what give rise to tdhTSCs, we sorted GFP^hi^ and GFP^lo^ WIBR3 OCT4-ΔPE-GFP naive-cultured cells into hTSC medium ([Figure 2](#fig2){ref-type="fig"}G). The GFP^hi^ hESCs (true naive) gave rise to ITGA2^+^ EpCAM^+^ cells with far higher efficiency, as demonstrated by fluorescence-activated cell sorting (FACS) 16 days later ([Figure 2](#fig2){ref-type="fig"}H). ITGA2^hi^ EpCAM^hi^ ITGA1^lo^ cells were sorted to give rise to an additional line, WIBR3 tdhTSC line 2 ([Figures 2](#fig2){ref-type="fig"}H and [S2](#mmc1){ref-type="supplementary-material"}D). The GFP^lo^ hESCs by contrast gave rise to very few ITGA2^+^ EpCAM^+^ cells ([Figure 2](#fig2){ref-type="fig"}H).

We also reverted and transdifferentiated a second embryonic stem cell line, UCLA1 ([@bib9]), via the same strategy ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F). All lines generated showed uniform staining for KRT7, TFAP2C, and TEAD4 ([Figure 2](#fig2){ref-type="fig"}I).

Validation of Putative Transdifferentiated hTSCs {#sec2.3}
------------------------------------------------

To confirm placenta-like identity of the putative tdhTSCs, we conducted RNA-seq of the starting hESC lines, tdhTSCs, and control placental (CT1, CT3) and blastocyst-derived (BT2) hTSCs. As a further comparison, we sequenced RNA from two epithelial cell lines: FT190-transformed fallopian tube epithelium and Hec116 endometrial carcinoma. A full list of samples and mapping statistics is in [Table S3](#mmc4){ref-type="supplementary-material"}, with gene expression levels in [Table S4](#mmc5){ref-type="supplementary-material"}.

Appropriately, tdhTSCs show dramatically reduced expression of core pluripotency transcription factors and gain of established placental markers and CTB/hTSC genes ([Figures 3](#fig3){ref-type="fig"}A and 3B). Minimal expression of amnion or somatic differentiation markers was observed. PCA of gene expression data showed three clear clusters: hESCs, hTSCs, and tdhTSCs, and non-placental epithelial lines ([Figure 3](#fig3){ref-type="fig"}C), with tdhTSCs intermingled with genuine hTSCs.Figure 3Validation that Transdifferentiated hTSCs Express Placental Genes(A) Gene expression of indicated markers in each sample type are indicated by coloration. Expression from replicates of each sample type are averaged. n = 2 (all tdhTSC lines), n = 3 (UCLA1 hESC), n = 4 (WIBR3 hESCs, CT3, BT2), n = 7 (CT1) biological replicates.(B) Same as (A) except with a different color scale.(C) Principal-component analysis for gene expression of the lines indicated. Each dot is one biological replicate.(D) Expression of 89 trophoblast-specific genes, as identified by analysis of pre-implantation primate embryos ([@bib25]), is indicated for each cell type. Expression of each gene, using an average of all replicates for a given cell type, is indicated as a single point on the violin plot. Box indicates 25th, 50th, and 75th percentiles. n = 1 (epithelial cell), n = 2 (all tdhTSC lines, naive hESCs), n = 3 (UCLA1 hESCs), n = 4 (WIBR3 hESCs, CT3, BT2), n = 7 (CT1) biological replicates.

Classifying cells as placental on the basis of expression of a small number of markers is controversial ([@bib37]). Classic pan-placental markers, such as TFAP2C, GATA3, and KRT7 are expressed in many non-placental tissues, as are the hTSC/CTB genes ELF5, TP63, and TEAD4 ([@bib49]). Even the pregnancy hormone hCG is produced in pituitary cells ([@bib6]). Therefore, we used a non-biased approach to identify genes expected to show increased expression in placenta. We analyzed gene expression data from early primate embryogenesis ([@bib25]) and identified 107 genes specific to trophoblast as compared with epiblast, hypoblast, and gastrulating cells, 89 of which were expressed (reads per kilobase of transcript per million mapped reads \[RPKM\] \> 1) in at least one of our RNA-seq samples ([Table S5](#mmc6){ref-type="supplementary-material"}). As predicted, hTSCs show dramatically higher expression of these trophoblast-specific genes than do pluripotent or epithelial cells ([Figure 3](#fig3){ref-type="fig"}D). Crucially, tdhTSC lines express trophoblast genes at levels similar to hTSCs of placental origin.

Moreover, the tdhTSCs show other classic hallmarks of placental identity ([@bib17]). They exhibit high expression of microRNAs generated from the Chromosome 19 microRNA cluster (C19MC) ([Figure S3](#mmc1){ref-type="supplementary-material"}A), demethylation of the *ELF5* promoter ([Figure S3](#mmc1){ref-type="supplementary-material"}B), and reduced staining with pan-HLA antibody relative to non-placental epithelial cell lines ([Figure S3](#mmc1){ref-type="supplementary-material"}C). They were also capable of directed differentiation to STB lineage, upregulating STB markers and secreting large quantities of hCG ([Figures 4](#fig4){ref-type="fig"}A, 4B, [S4](#mmc1){ref-type="supplementary-material"}A, and S4C). Differentiation of WIBR3 tdhTSCs to EVT lineage resulted in spindle-shaped morphology, gain of the EVT markers ITGA1 and HLA-G, and upregulation of EVT genes ([Figures 4](#fig4){ref-type="fig"}A, 4C, [S4](#mmc1){ref-type="supplementary-material"}B, and S4C). UCLA1 tdhTSC L1 show impaired differentiation to mature EVTs ([Figure 4](#fig4){ref-type="fig"}A and data not shown), although so do some blastocyst-derived hTSC lines ([@bib31]).Figure 4Differentiation Capacity of tdhTSCs(A) qRT-PCR for markers of EVT (*GCM1*, *HLA-G*), and STB (*GCM1*, *CGB7*) differentiation of lines indicated, normalized to *GAPDH*. Error bars indicate mean + SE for n = 3--5 independent experiments. ^∗^p \< 0.05 in one-tailed t test.(B) ELISA assay for hCG secretion after directed differentiation to STB. Error bars indicate mean + SE for n = 2 biological replicates, except CT1 for which there is one replicate.(C) Flow cytometry of hTSCs and EVT, for the EVT markers HLA-G and ITGA1, for the lines indicated. Representative of n = 5 independent experiments.

Combined, these results demonstrate similarity of tdhTSCs to genuine hTSCs.

Gain of Placenta-like DNA Methylation Pattern in tdhTSCs {#sec2.4}
--------------------------------------------------------

The placenta has a highly distinctive DNA methylation profile compared with hESCs or somatic cells. Global methylation levels are much lower in placenta and especially low in hTSCs ([@bib31]). Despite this reduced overall DNA methylation level, some CpG islands have increased DNA methylation in placenta and hTSCs, a pattern that is often recapitulated in the CpG island methylator phenotype, which occurs in many somatic cancers ([@bib39]). We sought to determine whether tdhTSCs acquired this distinctive placenta-like methylome. Also, because DNA methylation is a highly heritable mark, we reasoned that even if tdhTSCs have acquired an overall hTSC-like phenotype, they might still bear traces of their cell of origin or their period as naive hESCs.

We performed whole-genome bisulfite sequencing of CT1, CT3, WIBR3 primed hESCs, and WIBR3 tdhTSC line 1 and line 2 ([Table S3](#mmc4){ref-type="supplementary-material"}). Methylation levels and patterns observed for CT1 and WIBR3 hESCs are similar to published data ([Figures 5](#fig5){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A). The global CpG DNA methylation level of the tdhTSCs is similar to that of placental hTSCs and far lower than that of hESCs ([Figure 5](#fig5){ref-type="fig"}A). The methylation level of individual CpG islands and gene promoters in tdhTSCs is far better correlated with that of placental hTSCs than with hESCs ([Figures 5](#fig5){ref-type="fig"}B, 5C, and [S5](#mmc1){ref-type="supplementary-material"}B). On a global level, tdhTSCs appear to acquire a placenta-like methylome.Figure 5Global Methylation Patterns of tdhTSCFor all data, data in parentheses indicate data mined from published sources, data without parentheses indicate original data.(A) Global CpG methylation level in samples indicated.(B) Correlation of CpG island methylation in each of the two samples is indicated. Each CpG island represents as a single point, all CpG islands with adequate coverage are plotted.(C) Correlation of promoter methylation between two samples is indicated. All autosomal promoters with adequate coverage are plotted.(D) Violin plot indicating degree of CpG island methylation in samples indicated among 788 CpG islands that show higher DNA methylation in CT1 hTSCs relative to primed hESCs.(E) DNA methylation of a region of genome that includes the CpG island promoter of *NODAL*. Height of bars corresponds to percentage CpG methylation, from 0% to 100%. Data from WIBR3 tdhTSC L1 and L2 are merged to allow sufficient sequencing depth for visualization.(F) Violin plot showing methylation level of 2,107 promoters that show higher DNA methylation in primed hESCs relative to CT1 hTSCs.(G) Expression of 172 possible "gatekeeper" genes, genes that have upregulated expression in hTSCs and higher promoter methylation in hESCs. Expression of each gene, using an average of all replicates for a given cell type, is indicated as a single point on the violin plot. Box indicates 25th, 50th, and 75th percentiles. n = 2 (all tdhTSC lines), n = 3 (UCLA1 hESCs), n = 4 (WIBR3 hESCs, CT3, BT2), n = 7 (CT1) biological replicates.

We then focused on the phenomenon of placenta-specific CpG island methylation. We used published data to identify 788 CpG islands with substantially higher methylation in CT1 hTSCs compared with WIBR3 hESCs (see [Experimental Procedures](#sec4){ref-type="sec"} and [Table S6](#mmc7){ref-type="supplementary-material"}). Interestingly, these CpG islands include the promoters of genes critical for neural lineage (*SOX1*, *PAX6*), cardiac development (*HAND2*, *NKX-2.5*), and transforming growth factor β family signaling (*NODAL*, *FOXH1*), suggesting that DNA methylation may be a mechanism for shutting off these lineages in placenta. The WIBR3 tdhTSCs show a strong increase in DNA methylation at these 788 CpG islands relative to primed cells ([Figures 5](#fig5){ref-type="fig"}D and 5E), demonstrating that tdhTSCs have gained placenta-specific methylation.

We next considered the phenomenon of "gatekeeper" genes: key placental genes whose promoters are methylated in hESCs, thus precluding conversion to placental fate. Analogous methylation is a critical obstacle to complete conversion of murine ESCs to mTSCs ([@bib4]). To address this question, we identified 2,107 promoters methylated in WIBR3 hESCs that show dramatically lower DNA methylation in CT1 hTSCs (see [Experimental Procedures](#sec4){ref-type="sec"} and [Table S6](#mmc7){ref-type="supplementary-material"}). These regions show dramatic loss of methylation in WIBR3 tdhTSCs ([Figure 5](#fig5){ref-type="fig"}F). Of these genes, 172 are upregulated in hTSCs relative to primed hESCs and have an average RPKM \> 1 in hTSCs, possible gatekeepers ([Table S6](#mmc7){ref-type="supplementary-material"}). This set includes key placental factors, including *ELF5* and a number of hCG and STB fusion genes. Globally, these genes show increased expression in tdhTSC lines, comparable with placental hTSCs ([Figure 5](#fig5){ref-type="fig"}G). There is thus no general inability to reactivate placental gene expression in tdhTSCs, even at genes whose promoters are heavily methylated in starting hESCs.

Dysregulation of Select Imprinted Genes in tdhTSCs {#sec2.5}
--------------------------------------------------

Nonetheless, we detected examples of aberrant methylation in tdhTSCs in which their past as naive or primed hESCs was apparent. As expected, many imprinted regions showed aberrant hypomethylation in hTSCs ([Figure 6](#fig6){ref-type="fig"}A), a predictable consequence of having once been naive hESCs ([@bib32]). More surprisingly, three imprints showed selective hypermethylation in tdhTSC: *PEG3*, *ZFAT*, and *PROSER2-AS1*. *PEG3* is low expressed in primed hESCs and is prone to hypermethylation in culture, while *ZFAT* and *PROSER2-AS1* are placental imprints that converge toward methylation in pluripotent and somatic cells ([@bib3], [@bib15]). Apparently, they resisted demethylation in both the naive and trophoblastic states.Figure 6Imprinting Abnormalities in tdhTSC(A) CpG methylation level of all universal (organism-wide) and placental imprints in cell types indicated. CTB, primary cytotrophoblasts; L1, WIBR3 tdhTSC L1; L2, WIBR3 tdhTSC L2. CTB data from [@bib15], original data shown for all other samples.(B) Volcano plot of genes differentially expressed in hTSCs (CT1, CT3, and BT2) versus primed (WIBR3 and UCLA1 hESCs). Red dots correspond to differentially expressed genes (p~adj~ \< 0.05, fold-change \> 4).(C) Volcano plot of genes differentially expressed in hTSCs (CT1, CT3, and BT2) versus tdhTSCs (WIBR3 tdhTSC lines 1, 2, and 3, and UCLA1 line 1). Red dots correspond to differentially expressed genes (p~adj~ \< 0.05, fold-change \> 4).

We calculated differentially expressed genes, comparing hTSCs with both primed hESCs and tdhTSCs ([Figures 6](#fig6){ref-type="fig"}B and 6C; [Table S7](#mmc8){ref-type="supplementary-material"}). Very few genes show substantial dysregulation in tdhTSCs relative to hTSCs, but they include *PEG3*, *ZFAT*, and *PROSER2-AS1*, all of which show striking downregulation consistent with their hypermethylation ([Figures 6](#fig6){ref-type="fig"}C and [S6](#mmc1){ref-type="supplementary-material"}). In summary, while tdhTSCs have a broadly hTSC-like methylome, they do carry vestiges of their past that have some impact on their transcriptional program.

Conversion of Non-naïve Cells to hTSC-like Cells {#sec2.6}
------------------------------------------------

A recent report details the generation of "expanded potential stem cells" (EPS cells). EPS cells have a transcriptional program and level of DNA methylation similar to primed hESCs but can reportedly be differentiated into trophoblast by treatment with BMP4. When cultured in hTSC medium, trophoblast-like colonies can be identified, picked, and propagated ([@bib11]). A second report countered the first claim, showing that EPS cells treated with BMP4 formed cells with amnion-like, rather than trophoblast-like, properties ([@bib12]). However, it remained unclear whether tdhTSCs could be derived from EPS hESCs, so we analyzed RNA-seq data from the EPS-derived tdhTSCs. Although they were not sequenced in parallel with placental hTSCs, making direct comparison difficult, they express trophoblast genes at levels similar to placental hTSCs ([Figure S7](#mmc1){ref-type="supplementary-material"}A) and do not express amnion-specific genes at high levels ([Figure S7](#mmc1){ref-type="supplementary-material"}B). Interestingly, two of the three tdhTSC lines made from EPS cells showed low *PEG3* expression, and all showed low *ZFAT* and *PROSER2-AS1* expression ([Figure S6](#mmc1){ref-type="supplementary-material"}).

To perform a direct comparison, we grew three hESC lines (WIBR3, UCLA1, and H9) in naive medias (5iLAF, PXGL), in medias that produce cells with a mixture of naive and primed properties (EPS, RSet), and in primed medium, and subsequently transferred them to hTSC medium for 15 days. Surprisingly, all conditions were able to produce at least some population of ITGA2^hi^ EpCAM^hi^ ITGA1^lo^ cells ([Figures 7](#fig7){ref-type="fig"}A and [S7](#mmc1){ref-type="supplementary-material"}C; [Table S2](#mmc3){ref-type="supplementary-material"}). However, naive conditions generally produced more efficient transdifferentiation as measured by production of ITGA2^hi^ EpCAM^hi^ ITGA1^lo^ cells ([Figure S7](#mmc1){ref-type="supplementary-material"}C). WIBR3 cells had markedly inefficient transdifferentiation from EPS medium ([Figure S7](#mmc1){ref-type="supplementary-material"}C), to the extent that we were not able to isolate a pure line. Furthermore, while tdhTSC lines isolated from naive cells showed uniformly low staining for the amnion marker ITGB6 ([@bib12]), lines generated from EPS, RSet, or primed UCLA1 or H9 cells showed heterogeneous staining for this mark and higher expression as measured by RT-PCR ([Figures 7](#fig7){ref-type="fig"}B--7D). Expression of the gene *HAVCR1*, specific to trophoblast over amnion ([@bib12]), was uniformly higher in tdhTSCs generated from naive cells ([Figure 7](#fig7){ref-type="fig"}D). Finally, while naive hESCs gave rise to uniformly TEAD4^+^ TFAP2C^+^ KRT7^+^ tdhTSC colonies after sorting, EPS, RSeT, and primed-derived tdhTSCs contained a second population of cells with markedly lower TEAD4 staining ([Figure S7](#mmc1){ref-type="supplementary-material"}D). It remains unclear whether EPS, RSet, and primed cells gave rise to a mixture of hTSCs and amnion-like cells, or cells with properties of both, but naive cells are clearly optimal for generation of hTSCs.Figure 7Comparative Transdifferentiation Capacity from Different Media Conditions(A) Flow cytometry of UCLA1 hESCs cultured in various conditions and then grown in hTSC medium for 15 days. Percentage of ITGA2^hi^ EpCAM^hi^ cells is indicated.(B) Flow cytometry 20 days after sorting. Note higher ITGB6 signal in putative tdhTSCs derived from hESCs in non-naive conditions.(C) Flow cytometry histogram of ITGB6 signal for putative tdhTSCs derived from hESC lines, and growth condition indicated.(D) qRT-PCR quantification of placental markers and *ITGB6* in indicated cell lines normalized to *GAPDH*. W3, WIBR3; U1, UCLA1. ^∗^WIBR3 EPS-derived tdhTSCs could not be studied because conversion efficiency was too low to produce a pure ITGA2^hi^ EpCAM^hi^ line. n = 1 biological replicate.

Discussion {#sec3}
==========

We find that naive hESCs can be converted into hTSC-like cells. Very recently, another report also demonstrated production of hTSC-like cells from naive hESCs ([@bib10]). Whereas we cultured naive cells in hTSC medium for 10--22 days and purified tdhTSCs using surface markers, Dong and colleagues cultured naive cells in hTSC medium for 5--10 passages and report pure tdhTSC lines. There is an unproven but plausible reconciliation of these findings: successfully transdifferentiated tdhTSCs may grow faster than other cell types in mixed transdifferentiations, and may dislodge other cells as tdhTSC colonies expand, resulting in their taking over mixed cultures even without sorting.

Imprinting in tdhTSCs {#sec3.1}
---------------------

It is probably impossible to generate perfectly placenta-like tdhTSCs from hESCs by any current method. Certain parental imprints are retained only in placenta and accordingly these regions show biallelic hyper- or hypomethylation in hESCs ([@bib30]). hESC lines frequently show aberrations even in non-placental imprints ([@bib38]), and culture in naive conditions results in widespread imprint erasure ([@bib32], [@bib45]). Considering the importance of imprinting in placental development, it is somewhat remarkable that tdhTSCs are as similar to hTSCs as they are. Human conceptuses that lack maternal imprinting give rise to hydatidiform moles, aberrant placentas with little or no embryonic tissue ([@bib26]). Nonetheless, only three imprinted genes failed to activate upon transdifferentiation. The failure to reactivate *PEG3* is somewhat surprising, because this imprint is demethylated and chromatin-opened in naive hESCs ([@bib32]). This may be a consequence of the relatively brief period in which the hESCs used in this study were cultured in naive medium. *ZFAT* and *PROSER2-AS1* by contrast do not show open chromatin in naive hESCs ([@bib32]), are not reactivated in tdhTSCs derived from EPS cells, and may be the most refractory to activation in tdhTSCs.

More surprising is two imprints which were not differentially expressed: *IGF2* and *CDKN1C*. Demethylation of the H19 and KvDMR1 loci, respectively, should be expected to abrogate long-range promoter-enhancer interactions necessary for the expression of these two genes ([@bib40]). *CDKN1C* is of particular note because it is strongly implicated in molar pathology, and its loss eliminates contact inhibition in hTSCs ([@bib42]). However, expression of these genes was highly variable across both hTSC and tdhTSC replicates and trended lower in tdhTSCs ([Table S3](#mmc4){ref-type="supplementary-material"}).

Transdifferentiation Capacity of Human Pluripotent Cells {#sec3.2}
--------------------------------------------------------

While we show that naive hESCs are more efficient in transdifferentiating to tdhTSCs, it remains unclear whether hTSC-like cells can be generated from non-naive cells or how such cells might be different or impaired. There are now reports of generation of trophoblast-like cells from EPS cells ([@bib11]), primed hESCs treated with BMP4 and an S1P3 agonist ([@bib23]), and primed hESCs cultured in micromesh ([@bib19]). Our results certainly do not rule out this possibility. However, distinguishing tdhTSCs from contaminating, possibly amnion-like cells, is not a trivial endeavor: the contaminating cells share surface markers (ITGA2, ITGA6, and EpCAM) and show only subtle morphological differences from hTSCs. Amnion expresses many of the same core transcription factors as placenta ([@bib12]). Amnion identity must be firmly ruled out, preferably by direct comparison with placental hTSCs.

While hESCs can convert to tdhTSCs, naive murine ESCs require genetic manipulation to make such a transition and even then do so incompletely ([@bib4]). There are at least two possible explanations, which are not mutually exclusive: human naive pluripotent cells may reflect an earlier developmental state than murine naive cells or human pluripotent cells may retain greater plasticity than previously appreciated. The latter phenomenon deserves serious consideration. Remarkably, cells from day 5 human blastocysts (stage BL3), if harvested and reaggregated into an empty zona pellucida, will compact and cavitate, forming blastocysts of normal appearance with a NANOG^+^ ICM ([@bib8]). Similar results are obtained if only outer (trophectoderm) or inner (ICM) cells are added to an empty zona pellucida, implying that lineage is not restricted until well after blastocyst formation. Furthermore, the barrier to placental transdifferentiation is sometimes crossed in the context of malignancy: early germ cells, which reactivate much of the transcriptional program of the pluripotent epiblast, can give rise to choriocarcinomas (trophoblast-like tumors) in both mice and humans ([@bib1], [@bib36]). Future studies may also indicate when and how in human development a firm barrier to placental differentiation is established.

Experimental Procedures {#sec4}
=======================

TSC Culture and Differentiation {#sec4.1}
-------------------------------

hTSCs were cultured according to published protocol ([@bib31]) with the following alterations. 0.5--1 × 10^5^ cells were plated on each well of a 6-well plate, and cells were passaged every 5--7 days. We observed that reduced oxygen levels promote hTSC self-renewal but inhibit directed differentiation, so we cultured hTSCs in 5% O~2~ 5% CO~2~ but performed differentiation to EVT or STB at 20% O~2~ 5% CO~2~.

EVT and STB differentiation were performed according to published protocol, with the following alterations. For STB differentiation the density of the cells when plated was doubled to 150,000 per 6-well plate well and cells were cultured for 3 days in STB (2D) medium before collection and assessment. For EVT, 150,000 cells were plated initially, but procedures for differentiation remained unchanged.

The three lines described in this paper as CT1, CT3, and BT2 correspond to the published lines TS^CT1^, TS^CT3^, and TS^BLAST2^, respectively([@bib31]).

Embryonic Stem Cell Culture {#sec4.2}
---------------------------

Primed hESCs were routinely cultured with TeSR-E8 (StemCell Technologies) on hESC Qualified Matrigel (Corning). hESCs were reverted to naive state using a one-step induction adapted from published protocols ([@bib13]). Further details are provided in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

For consistency, all stem cells used in RNA-seq were cultured in 5% O~2~.

Transdifferentiation of Naive hESCs to hTSC Culture {#sec4.3}
---------------------------------------------------

Naive hESCs were passaged to Matrigel (Corning)-coated plates at 20%--30% confluency into TSC culture medium. Cells were grown on collagen-coated plates in subsequent passages, akin to control hTSCs. Cells were grown to confluency before fluorescent cell sorting, which is described further in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

STR Analysis {#sec4.4}
------------

STR analysis was performed at the SickKids Center for Applied Genomics Facility using GenePrint10 (Promega).

hCG ELISA {#sec4.5}
---------

hCG secretion was measured using an hCG AccuBind ELISA (Monobind) according to manufacturer instructions.

Generation of RNA-Seq Libraries {#sec4.6}
-------------------------------

RNA extraction was performed using QIAGEN RNeasy Micro Kit, except for two samples (WIBR3 primed replicate 1, WIBR3 naive day 10) that were extracted using RNAzol RT (Sigma). RNA quality was confirmed using Bioanalyzer. mRNA was enriched from 500 ng total RNA using NEBNext Poly(A) mRNA Magnetic Isolation Module Kit and libraries were generated using Swift RNA Library Kit.

Samples were run on an Illumina NovaSeq instrument at the La Jolla Institute for Allergy and Immunology Sequencing Core, or on a HiSeq 4000 at Michael Smith Genome Sciences Center. Three samples were sequenced at both locations to confirm similarity of results.

RNA-Seq Analysis {#sec4.7}
----------------

### Mapping and RPKM Calculation {#sec4.7.1}

FASTQ files were mapped to hg19 using the STAR aligner (v2.5.3a) with default parameters. Bam files were analyzed by RNA-SeQC to confirm library quality. Read counts were calculated with htseq-count and RPKM was calculated using cufflinks (v2.2.1) with default settings.

### PCA {#sec4.7.2}

PCA was performed using prcomp function in R and plotted with the ggfortify package. Genes with RPKM \< 2 in all samples were excluded from analysis.

### Identification of Trophoblast-Specific Genes {#sec4.7.3}

Cynomolgus monkey single-cell RNA-seq data normalized using the RPM method were obtained from [@bib25]. Trophoblast-specific genes were identified by calculating differentially expressed genes between trophoblast cells (11 cells each in the categories "Pre-implantation Early trophoblast," "Pre-implantation late trophoblast," and "Post-implantation parietal trophoblast") and all other cells. Differentially expressed genes were identified as false discovery rate (FDR) \< 0.05 using the kruskal.test function and p.adjust function in R. As a further filter, trophoblast-specific genes were required to show at least 4-fold higher expression in placental cells over all non-placental cell types and to have an average RPM \> 7 in placental cells.

### Differential Gene Expression Calling and Volcano Plot {#sec4.7.4}

Read counts obtained from htseq-count were used for differential gene expression with DESeq2. Genes with raw read count \>100 were plotted using EnhancedVolcano package in R.

Generation of Whole-Genome Bisulfite Sequencing Libraries {#sec4.8}
---------------------------------------------------------

Genomic DNA was collected using a QIAGEN Blood and Tissue Kit, including RNase A treatment. DNA concentration was measured using Nanodrop. DNA (500 ng) was fragmented using a Covaris M220 instrument and 250 ng was processed with a Zymogen bisulfite conversion kit. The equivalent of 50--100 ng of DNA was used to generate the sequencing library with the Accel-NGS Methyl-Seq DNA Library Kit (Swift Biosciences).

Libraries were sequenced as 150-bp paired-end reads at the Michael Smith Genome Sciences Center on a HiSeq 4000 instrument.

Bisulfite Sequencing Analysis {#sec4.9}
-----------------------------

The adaptor sequences of paired-end 150 bp WGBS raw reads were first trimmed based on the FastQC (v.0.11.8) report using Cutadapt (v.1.9.1) ([@bib21]). Then the last 15 bp of read1 and first 15 bp of read2 were cut according to Swift kits manual using Cutadapt (v.1.9.1) ([@bib21]). Trimmed paired-end reads were then aligned to human reference genome (GRCh38) using BSMAP (v.2.7.4) ([@bib51]) allowing two mismatches. Methylation levels over each cytosine were then calculated using BSMAP (v.2.7.4) methratio.py scripts. Potential unconverted reads were removed with a customized function incorporated in the methratio.py script ([@bib7]). Methylation levels over different genomic regions were extracted using a customized Python script. Differentially methylated regions (DMRs) were defined using CT1 ([@bib31]) and WIBR3 ([@bib45]) with customized R script over promoters and CpG islands regions. Promoters were defined as upstream 1 kb and downstream 200 bp of transcription start site. Chromosome Y was excluded from the DMR analysis. Regions with coverage (C + T count) greater than 50 in both samples were kept. p values were calculated with Fisher's exact test and then adjusted with the Benjamini-Hochberg procedure (FDR).

Additional thresholds were then applied. To identify regions with CT1-specific CpG island methylation, we required (1) FDR \< 0.05, (2) a ≥25% absolute difference in CpG methylation level between CT1 hTSCs and WIBR3 hESCs, and (3) ≥50 CTs mapped over the region in all eight bisulfite sequencing samples. To identify regions with hESC-specific promoter methylation, we required (1) FDR \< 0.05, (2) a ≥50% absolute difference in CpG methylation level between CT1 hTSCs and WIBR3 hESCs, and (3) ≥50 CTs mapped over the region in all 8 samples.

ELF5 Methylation Analysis {#sec4.10}
-------------------------

The ELF5 promoter was amplified using primers described previously ([@bib17]). Further details are contained in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Alterations to Images {#sec4.11}
---------------------

Brightness and contrast of light microscopy images was uniformly altered in some figures to enhance clarity.

Ethical Permissions {#sec4.12}
-------------------

All experiments were approved by the McGill University Faculty of Medicine institutional review board and the CIHR Stem Cell Oversight Committee.

Data and Code Availability {#sec4.13}
--------------------------

RNA-seq and bisulfite sequencing data have been deposited to the Gene Expression Omnibus database under the accession number [GSE152104](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152104){#PC_linkTUHzhMhJP1}.

Author Contributions {#sec5}
====================

J.K.C., S.Y.K., I.H., J.S., C.S.R., and H.-W.T. conducted the experiments. S.Y.K. and Y.G. conducted the bioinformatic analysis. H.O. and T.A. provided hTSC lines and technical advice. T.F.D., W.L., and W.A.P. supervised the experiments and analysis.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S7Table S1. STR Analysis of WIBR3 hESCs and TSCs, Related to Figure 2Table S2. Descriptions of Transdifferentiations, Related to Figures 2 and 7Description of circumstances of generation of each cell line, efficiency of production of ITGA2hi EpCAMhi and ITGA2hi EpCAMhi ITGA1lo cells, and figures in which each cell line was used.Table S3. Sample Description and Mapping Statistics, Related to Figures 3, 5, and 6Table S4. RPKM of All Samples, Related to Figures 3, 5, and 6Table S5. Expression of Trophoblast-Specific Genes in RNA-Seq Samples, Related to Figure 3Expression data used to generate Figure 3D.Table S6. Methylation Data, Related to Figures 5 and 6CpG islands with CT1-hTSC-specific methylation, promoters with hESC-specific methylation, and putative gatekeeper genes and their expression levels in different samples are all shown.Table S7. Genes Differentially Expressed between Control hTSCs and tdhTSCs, Related to Figure 6First two panels: Genes that show differential expression between hTSCs (CT1, CT3, BT2) and primed hESCs (WIBR3, UCLA1) are listed, along with fold-change and log~2~ read count per million. Positive fold-change value indicates higher expression in hESCs. Third and fourth panels: Genes that show differential expression between control hTSCs (CT1, CT3, BT2) and tdhTSCs (WIBR3-tdhTSC Line 1, WIBR3-tdhTSC Line 2, UCLA1 tdhTSC) are listed. Positive fold-change value indicates higher expression in tdhTSCs.Document S2. Article plus Supplemental Information

We thank the Goodman Cancer Research Center Flow Cytometry core, the SickKids Center for Applied Genomics Facility, the La Jolla Institute for Allergy and Immunology Sequencing Core, and the Canada Michael Smith Genome Sciences Center at BC Cancer for their dedicated service. We thank the Rudolph Jaenisch (MIT) and Thorold Theunissen (Washington University) labs for providing WIBR3 OCT4-ΔPE-GFP hESCs, and the Amander Clark lab (UCLA) for providing UCLA1 hESCs. This work was funded by the New Frontiers in Research Fund (NFRF) grant NFRFE-2018-00883 and the 10.13039/501100000024Canadian Institutes of Health Research (CIHR) project grant PJT-166169 to W.A.P., the 10.13039/501100004731Zhejiang Provincial Natural Science Foundation of China, LQ20C060004 to W.L., and PJT-165996 to T.F.D. J.K.C. was supported by a Fonds de recherche Santé Québec graduate fellowship. J.K.C. and I.H. were supported by studentships from the McGill University Faculty of Medicine.

Supplemental Information can be found online at <https://doi.org/10.1016/j.stemcr.2020.06.003>.
